UPCOMING SERIES: Efficacy and Safety of Subcutaneous Spesolimab for the Prevention of Generalised Pustular Psoriasis Flares (Effisayil 2): an International, Multicentre, Randomised, Placebo-Controlled TrialByBruce Strober, MD, PhD,Aaron S. Farberg, MDSeptember 30th 2024